INIGEM   23989
INSTITUTO DE INMUNOLOGIA, GENETICA Y METABOLISMO
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
GOS/FOS-CONTAINING INFANT FORMULAE AND BONE HEALTH BENEFITS IN WEANING RATS
Autor/es:
BRYK G; GONZALES CHAVES MMS; MAROTTE C; ZENI CORONEL M; DE PORTELA ML; ZENI SN
Lugar:
Estocolmo
Reunión:
Congreso; 39th Annual Congress of the European Calcified Tissue Society (ECTS); 2012
Institución organizadora:
European Calcified Tissue Society (ECTS)
Resumen:
GOS/FOS-CONTAINING INFANT FORMULAE AND BONE HEALTH BENEFITS IN WEANING RATS. 1,2Bryk G, 1,2,3Gonzales Chaves MMS, 1,2,3Marotte C, 1Zeni Coronel M, 4de Portela ML, 1,2,3Zeni SN. 1Osteopaties Section, Clinical Hospital; 2Dep. of Biochemistry, School of Dentistry; 3CONICET; 4Dep. of Nutrition, School of Biochemistry, Buenos Aires University. Combined Galacto-oligosaccharides (GOS) and Fructooligosaccharides (FOS) are mainly added to infant formula to promote the prevalence of a microbiota composition similar to that resulting from breast-fed infants. Their efficacy evaluated in paediatric population had methodological limitations and their mechanisms are still under debate. According to our knowledge they are not experimental studies during the high growth period in order to determine the potential bone health benefits of the consumption of GOS/FOS containing infant formula.